Last reviewed · How we verify
Testosterone Patches
At a glance
| Generic name | Testosterone Patches |
|---|---|
| Sponsor | VA Office of Research and Development |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance (PHASE4)
- A Deep Learning Method to Evaluate QT on Ribociclib
- Adaptions and Resiliency to Multi-Stressor OpeRations (PHASE4)
- Transgender Estradiol Affirming Therapy (PHASE2)
- A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer (PHASE1)
- Polycystic Ovary Syndrome (PCOS) and Sleep Apnea (PHASE4)
- Bone Loss in Women With Anorexia Nervosa (PHASE2, PHASE3)
- Hormonal Factors in the Treatment of Anorexia Nervosa (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Testosterone Patches CI brief — competitive landscape report
- Testosterone Patches updates RSS · CI watch RSS
- VA Office of Research and Development portfolio CI